The last thing Alan Rubin imagined he’d be doing after retiring from a successful career in financial services was helping his son run a hot dog cart. Then he was diagnosed with stage III kidney cancer, and found himself in another unexpected locale: Dana-Farber Brigham Cancer Center. Like the decision to join his son’s business … Read more
Anal cancer, which forms in tissues of the anus, the opening at the bottom of the rectum, is diagnosed in about 9,800 people each year in the United States, most often in older adults. It is more common in white women and Black men than other groups, and while it is a serious disease, it … Read more
Certain forms of cancer and cancer treatment can affect your vision and, in rare cases, cause vision loss. At Dana-Farber, our care teams will work with you to help you understand the possibilities, know what to look for, and take action to manage any vision changes that might occur. What types of cancer can cause … Read more
In early March of 2018, at age 58, Roger Miller went to a local doctor’s office in Maine for outpatient surgery. He’d been putting off getting what he’d thought was a cyst removed from the back of his head. During the procedure, he overheard the surgeon say, “Oh, this doesn’t look good.” Miller, who at … Read more
Animals — from oysters and corals to flies and mammals — encode proteins to sense their environment and share a common strategy to rally a defense. Scientists have identified a new family of immune proteins conserved across animal evolution with common features. Recent research from Dana-Farber Cancer Institute has added a new family to the … Read more
Pancreatic cancer often eludes early detection because symptoms typically don’t surface until the disease is well established. This makes it important to respond appropriately to warning signs, even though some may be vague or caused by another health condition. What are the symptoms of pancreatic cancer? Most symptoms of pancreatic cancer are caused when tumors … Read more
For years, patients with advanced forms of gastric and esophageal cancer have had relatively few treatment options. Most patients with inoperable tumors would receive chemotherapy, usually a combination of fluorouracil, oxaliplatin and leucovorin (known as FOLFOX). While this regimen is often effective, patients eventually develop resistance to the treatment and their tumors progress. Now, the … Read more
As a cast member on the television series “America’s Test Kitchen,” and host of its companion podcast “The Walk-In,” Elle Simone Scott delights in sharing her expertise and recipes. The Boston-based celebrity chef and food stylist is also a role model, as founder and president of SheChef, Inc., a professional networking organization for fellow women … Read more
In a branch of the PI3K protein family — with members named PI3Kα, PI3Kβ, PI3Kδ, and PI3Kγ — PI3Kβ was long treated as the proverbial middle child: neglected by cancer scientists in favor of its more prominent siblings. In a new study, Dana-Farber researchers demonstrate that it doesn’t deserve its obscurity — that in fact … Read more
Words like “chemobrain” and “chemofog” — terms now used by patients, doctors, and scientists to describe cognitive decline that some patients experience in response to cancer therapy — didn’t exist a few decades ago. Today, however, there’s a general awareness that cancer treatments can take a toll on the brain. Oncologists don’t yet have a … Read more
When researchers report the survival effect of a cancer drug in a clinical trial, they almost always use a measure called hazard ratio. For all its ubiquity, however, hazard ratio has a hazard of its own: it’s a bit tricky to understand. A 2019 study found that 47% of researchers misinterpreted hazard ratio (HR) when … Read more
For many patients with lymphoma or multiple myeloma, a stem cell transplant with their own stem cells (an autologous transplant) or CAR T-cell therapy can extend life significantly or even cure the disease. A variety of factors influence which of these two treatments is recommended, including: What is the difference between stem cell transplant and … Read more
Cari Carpenter is a pioneer. Coming of age athletically in the 1970s, when competitive sports were just opening up for young women, she paved the way for the next generation — including a daughter who played and now coaches college field hockey. It’s the same in her professional life, where Carpenter runs an innovative program … Read more
Brian Humberd firmly believes in an attitude of gratitude. The biotech recruiter from Melrose, Massachusetts remains eternally grateful to Dana-Farber medical oncologist David Fisher, MD, who not only recommended a life-saving stem cell transplant to treat his central nervous system (CNS) lymphoma, but whose advice enabled Humberd to become a father after his cancer treatments. … Read more
To understand the genesis of the bone marrow transplant field, go back to the detonation, in 1945, of the first nuclear weapons and the shadow of the Atomic Age. The search for ways to rescue the blood-forming and immune systems of individuals exposed to high doses of radiation provided the impetus for donor bone marrow … Read more
It may be the quintessential question about cancer therapy: why does a particular treatment work well in some patients and not others with the same disease? The question is especially relevant for immunotherapies known as CAR T-cell therapies precisely because they’re so promising. The therapies, which are made by genetically engineering a patient’s own immune … Read more
As a pediatric pharmacist located in Dana-Farber’s Jimmy Fund Clinic, Patrick never tires of seeing smiling, young cancer patients enjoying the clinic’s playroom. The resilience they display throughout infusions, blood draws, and other procedures not only inspires him, but it also serves as a source of resolve he carries into his ongoing cancer care. Patrick, … Read more
Uterine cancer — also known as endometrial cancer — has traditionally been classified as endometrioid or non-endometrioid based on the appearance of the tumor cells under a microscope. Now, as scientists learn more about the molecular makeup of the disease, uterine cancers are increasingly identified by the specific genetic alterations within them. Endometrioid uterine tumors … Read more
The rectum is a six-inch-long portion of the large intestine, which is about five feet in length, but it is the starting point of about one-third of the 145,000 cases of colorectal cancer diagnosed in the United States each year. About 5% of people will develop rectal cancer at some point, and about 11% will … Read more
Sixty years to the day after President John F. Kennedy’s landmark speech pledging to land an American on the moon by the end of the decade, President Biden came to Boston on September 12 to recommit the country to a different kind of moonshot — “ending cancer as we know it.” Speaking at the John … Read more